Episode 14: DCT Pioneer Laura Podolsky explains Decentralized Clinical Trials and what platforms, vendors, and investors need to know

In this episode you’ll discover:

  • Why Decentralized Clinical Trials (DCT) got a boost from the pandemic—and whether this boost is likely to continue

  • What benefits and drawbacks exist with DCT when compared to traditional clinical trials

  • How companies which support DCTs can gain access to these trials via the platforms (think: mobile nursing agencies, patient recruitment companies, and mobile labs)

  • What special privacy considerations are needed in DCT and how companies can adjust their processes to meet those needs

  • What investors and sponsors look for in a DCT platform during due diligence (including a handy resource)

Read More
Episode 13: Startup, Merger, and Mental Health Advice from CEO of Headspace Health, Russ Glass

In this episode you’ll discover:

  • Why Headspace and Ginger merged into Headspace Health (and how that partnership came to be)

  • Why Russ ventured into the digital health space after success in more traditional tech startups like Bizo (acquired by LinkedIn)

  • What Headspace Health is doing to improve adolescent mental health—and how it impacts society

  • Why Headspace Health decided to target the employer market before payers and direct-to-consumer models—and how those markets are expanding

  • What unexpected benefits you’ll get from a mentor if you’re open to it (and other founder advice!)

Read More
Episode 12: Hot Takes from #HLTH2021: Innovations, Industry Trends, and Major Announcements

In this episode you’ll discover:

  • Why Medicare is banking on 100% beneficiary participation in value-based care models by 2030

  • How the government is turning “payer-agnostic” on value-based care models by partnering with commercial payers and Medicaid

  • Why you’ll be glad this White House is reinvigorating CMS’s Health Care Payment Learning and Action Network (LAN)

  • Why providers and tech companies are embracing Full Risk Contracts and Payment Models

  • Why “Virtual Care is replacing “telemedicine” as the new umbrella term—and how it helps companies meet patients where they are

  • Why failure to adopt value-based care models could be an existential threat

  • What everyone is saying about RPM, RTM and care management

Read More
Episode 11: Insurance for Digital Health Innovators: A Surprising Conversation with Beracah Stortvedt of Marsh & McClennan Agency

In this episode you’ll discover:

  • What the unique risks for digital health companies are

  • Why your tech company might need medical practice insurance, or your practice’s telemedicine services might require errors and omissions coverage—and other surprising areas of risk in the digital health space

  • Why your coverage should overlap and “talk to each other” in these complex scenarios so you don’t have gaps

  • How multi-state telemedicine companies should evaluate insurance based on their complex needs

  • How much you should expect to pay for this

Read More
Episode #10: Obvious Truths Our Healthcare Policy Still Doesn't Support...

In this episode you’ll discover:

  • Why mental health is a vital aspect of maintaining overall health—and why the system is not set up to support that (right now)

  • How providers, payors, and tech companies can align incentives to achieve better outcomes and lower health costs

  • Why our system isn’t built for that kind of alignment yet—but it’s getting there

Read More
Episode #9: Digital Health Innovations as "Consumer Technology," with René Quashie, VP of Digital Health, Consumer Technology Association

In this episode you’ll discover:

  • How the Consumer Technology Association supports Digital Health innovators.

  • The most important issues CTA is focusing on in the Digital Health space

  • What we can look forward to at CTA’s Consumer Electronics Show in January 2022

Read More
Episode 8: Why Israel is known as the Startup Nation—and how it can help the US (with Antidote Health CEO)

In this episode you’ll discover:

  • Why this NY-based company still does so much R&D in Tel Aviv

  • What drove Antidote to create an AI-driven virtual HMO

  • How Antidote wants to help the large uninsured and underinsured populations in the US

  • And a fun final question we don’t want to give away

Read More
Episode #7: Innovation Insights from the Largest Medical Center in the World, Texas Medical Center

In this episode you’ll discover:

  • What the ecosystem of innovation looks like at TMC Innovations;

  • How TMC Innovations helps startups via accelerators, resources, and their venture fund;

  • How they’ve seen health system partners work with digital health companies;

  • How specific digital health startups are adapting and thriving during the pandemic; and

  • What they think is the most pressing need in healthcare in the next 3 years.

Read More
Episode #6: One Way Digital Health Companies Can Influence National Healthcare

Listen to discover:

  • What the MPFS is, and why this annual Proposed Rule is so important for digital health companies (plus a little history on CPT code 99091 and how it launched RPM reimbursement);

  • Why the agency in charge of these reimbursement rules (CMS) doesn’t always get it right;

  • How ‘Notice and Comment Rulemaking’ helps stakeholders influence regulations;

  • What to do when Congress doesn’t get it right;

  • Why you should pencil this time period into your calendar every year to examine the Proposed Rule to advocate on behalf of your company and industry.

Read More
Episode #5: 3 Emerging Opportunities for Life Science & Biotech Businesses w/ Innovation Attorney Tommy Miller

In this episode you’ll discover:

  • Biologics, including reimbursement, accelerated FDA approval pathways, what sector of the industry can speed growth for everyone, and the push for developing mRNA and gene editing therapeutics for difficult or rare disease states;

  • Software as a Medical Device (SaMD) and how the new “remote therapeutic monitoring” CPT codes revealed last week in the proposed 2022 MFPS will increase reimbursement options for mood and pain management—as well as the FDA’s investment in the Digital Center for Excellence to improve the regulation of SaMD;

  • Decentralized trials and home digital health tools and how these trends are expanding recruiting options and returning more realistic data because people are accessing and using these products at home.

Read More
Episode #4: Startup Advice from Clarify Health Solutions Co-founder Todd Gottula

In this episode you’ll discover:

  • What startups spend a ton of money on that is usually a waste

  • Which of the 3Ps are most important for growth

  • What key piece of advice Todd would give to a startup raising its first significant funding round

  • How important paid advisors are to the success of a startup—and when to lean on them

  • How to set pricing for your tech

Read More
Episode #3: Obvious Truths Our Healthcare Policy Still Doesn’t Support: Home Care and RPM

In this episode you’ll discover:

  • Why people prefer care at home, and what COVID-19, Amazon, and the Moving Health Home Coalition are doing to make that more of a reality

  • How remote patient monitoring (RPM) improves health outcomes—even though we make it hard for providers and patients to use it

  • What features innovators and investors should look for in healthcare solutions to build on these obvious truths

Read More
Episode #2: Healthcare Innovation as a Matter of National Security

In this episode you’ll discover:

  • When we aren’t actively facilitating healthcare innovation, we put our national security at risk. Think about how long it took people to get a telehealth visit for chronic or acute conditions during the first months of the pandemic. If we can’t keep our people healthy, how secure are we?

  • If telehealth reimbursement passed in 1997, why did it take until 2020 for the first nationwide, full-service telehealth provider to expand its medical services to include Medicare Part B coverage?

  • Regulations that protect patient safety are important, but need to facilitate innovation. We’ll talk about a few resources for this, as well as how far we still have to go.

Read More